Simain vaccine evaluation units
Ended Awarded Last action
- Contract number
- HHSN27200002
- Awardee
-
Bioqual, Inc. UEI CK9LGQ7EBNN8
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,459,332
Award facts
- Opportunity
-
- NIAIDDAIDSNIHAI2012138 Solicitation number
- Contract value 46% obligated
-
- $1,459,331.56 Current, with exercised options
- $3,143,338.56 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 6 offers Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$5,953 | |
| Funding Only Action | -$40,280 | |
| Funding Only Action | -$8,727 | |
| Funding Only Action | $7,315 | |
| Funding Only Action | -$127,450 | |
| Funding Only Action | -$18,060 | |
| Funding Only Action | -$66,327 | |
| Funding Only Action | -$83,817 | |
| Funding Only Action | -$19,765 | |
| Exercise an Option | $266,873 | |
| Exercise an Option | $261,256 | |
| Funding Only Action | -$24,267 | |
| Exercise an Option | $255,699 | |
| Exercise an Option | $250,136 | |
| Exercise an Option | $98,388 | |
| Exercise an Option | $244,010 | |
| Exercise an Option | $237,885 | |
| Other Administrative Action | $0 | |
| Original award | $232,415 |
Show all 19
About this award
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a delivery order valued at $3.14 million to Bioqual, Inc. for the conduct of Study P172 under the Simian Vaccine Evaluation Units master IDIQ contract (2013-2020). This cost-plus-fixed-fee delivery order, awarded May 1, 2013, with an ultimate completion date of April 22, 2023, supports NIAID's research infrastructure for evaluating vaccine candidates and countermeasures against infectious diseases using non-human primate models. Bioqual, a biomedical research services company based in Rockville, Maryland, specializes in providing advanced animal research and laboratory analysis support to federal health agencies. No set-aside designation was applied to this award.
The delivery order represents work within Bioqual's broader strategic engagement with NIAID on vaccine development and infectious disease research. As the prime contractor, Bioqual leverages its expertise in non-human primate models—a critical component of preclinical vaccine evaluation—to support NIAID's mission of developing and refining animal models for assessing medical countermeasures. This engagement reflects Bioqual's established role within NIAID's research ecosystem, complementing the company's participation in larger indefinite delivery contracts, including a $146.3 million single-award IDC for animal model development running through July 2031.
Quick answers
Who was awarded contract HHSN27200002?
HHSN27200002 was awarded to Bioqual, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on May 1, 2013.
How much is contract HHSN27200002 worth?
The government has obligated $1,459,332 on HHSN27200002. Its potential value, with all options, is $3,143,339.
Is contract HHSN27200002 an order under another contract?
Yes. HHSN27200002 is a delivery order under HHSN272201300003I, an indefinite delivery contract, on Simian Vaccine Evaluation Units 2013-2020.
Was contract HHSN27200002 competed?
The extent of competition for HHSN27200002 was full and open competition. The government received 6 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award